Finally, this finding may explain the paradox that the proneural type of GBM resists standard therapeutic caused by the cancer stem cells maintained by PATZ1 involved transcription factor networks, while at the same time PATZ1 restricts the proneural type of GBM to differentiation into mesenchymal type. The gene discussed is PATZ1; the disease is glioblastoma.